News & Events

Aspin Pharma proudly introduced its first ever cardiology product with the name of BISPA (Bisoprolol) in order to meet the ever increasing cardiology segment demands. Worldwide, raised blood pressure is estimated to cause 7.5 million deaths; about 12.8% of the total deaths. Unmanaged hypertension can lead to a heart attack, stroke, and other problems.

Keeping the needs of society and to cater the ever growing demand, BISPA is a perfect blend of quality at best price to fulfil these demands.

The launch ceremony and training for sales team was held at Dream World Resort in Karachi and at Hill View Hotel in Islamabad. The participants gained important medical and scientific updates regarding the disease and the related therapeutic area scope.